|1.||Diverio, Daniela: 2 articles (10/2005 - 08/2004)|
|2.||Testa, Ugo: 2 articles (10/2005 - 08/2004)|
|3.||Riccioni, Roberta: 2 articles (10/2005 - 08/2004)|
|4.||Peschle, Cesare: 2 articles (10/2005 - 08/2004)|
|5.||Tettamanti, S: 1 article (08/2014)|
|6.||Bonnet, D: 1 article (08/2014)|
|7.||Biondi, A: 1 article (08/2014)|
|8.||Anjos-Afonso, F: 1 article (08/2014)|
|9.||Spinelli, O: 1 article (08/2014)|
|10.||Rouault-Pierre, K: 1 article (08/2014)|
|1.||Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/01/2004 - "In a previous study we have shown that the interleukin-3 receptor alpha chain (IL-3Ralpha) is over expressed in about 45% of acute myeloid leukemias (AMLs) and this phenomenon was associated with high blast cell counts at diagnosis, high rate of cycling of leukemic blasts and with a worse prognosis. "
10/01/2005 - "Leukemic blasts from patients with acute myeloid leukemia (AML) frequently express high levels of the interleukin-3 receptor alpha chain (IL-3Ralpha). "
08/01/2004 - "Immunophenotypic features of acute myeloid leukemias overexpressing the interleukin 3 receptor alpha chain."
10/01/2000 - "The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells."
08/01/2014 - "Chimeric antigen receptors against CD33/CD123 antigens efficiently target primary acute myeloid leukemia cells in vivo."
06/01/2004 - "The tumor cells share a great phenotypical homology and particularly the expression of the CD123 antigen. "
09/01/2007 - "The recent discovery of CD123 antigen expression by tumor cells has provided evidence for a relationship to immature dendritic cells (DCs), a group of myeloid and lymphoid early-committed progenitors capable of differentiating into antigen-presenting DCs. "
10/01/2003 - "The morphologic, cytochemical and immunophenotypic features were compatible with those described in DC2 acute leukemia, with co-expression of CD4, CD56 and CD123 antigens. "
12/19/2003 - "Promyelocytic leukemia zinc finger (PLZF) protein is a sequence-specific DNA-binding protein that represses the transcriptional activity of target genes such as those for cyclin A and the interleukin-3 receptor alpha chain. "
|4.||Hematologic Neoplasms (Hematological Malignancy)
|2.||Antigen Receptors (Antigen Receptor)
|3.||DNA-Binding Proteins (DNA Binding Protein)